Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2

被引:58
作者
Inano, A
Sai, Y
Nikaido, H
Hasimoto, N
Asano, M
Tsuji, A
Tamai, I
机构
[1] Sci Univ Tokyo, Fac Pharmaceut Sci, Dept Mol Biopharmaceut, Shinjuku Ku, Tokyo 1620826, Japan
[2] CREST, Japan Sci & Technol Corp, Kawaguchi 3320012, Japan
[3] Kanazawa Univ, Fac Med, Inst Expt Anim, Kanazawa, Ishikawa 9208640, Japan
[4] Sci Univ Tokyo, Fac Pharmaceut Sci, Shinjuku Ku, Tokyo 1620826, Japan
关键词
blood-brain barrier; transport; acetyl-L-carnitine; OCTN2; microdialysis;
D O I
10.1002/bdd.371
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OCTN2 (SLC22A5), an organic cation/carnitine transporter, is widely distributed throughout the body, including the brain. In the present study, the involvement of OCTN2 in acetyl-L-carnitine (ALCAR) permeation across the blood-brain barrier (BBB) was examined using a microdialysis method in mouse. CCTN2 function was examined by comparison of wild-type mice with jvs mice, which express defective OCTN2 and are considered a model for primary systemic carnitine deficiency. Zero-net-flux method analysis indicated higher in vivo recovery of ALCAR and lower physiological ALCAR concentration in thalamus extracellular fluid (ECF) in jvs mice compared with wild-type mice. Externally added ALCAR showed significantly slower initial uptake across the BBB in jvs mouse. These results indicated that OCTN2 is functionally involved in ALCAR transfer across the BBB. Total radioactivity in ECF after i.v. administration of radiolabelled ALCAR remained constant for the rest of the experimental period. Accordingly, our results indicate that ALCAR is transported from blood to brain ECF by OCTN2 at least in part, and its concentration in brain ECF is regulated by other events such as protein binding and anabolic reactions in the brain, as well as by transport across the BBB. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 33 条
[1]   Acetyl-L-carnitine modulates glucose metabolism and stimulates glycogen synthesis in rat brain [J].
Aureli, T ;
Di Cocco, ME ;
Pucetti, C ;
Ricciolini, R ;
Scalibastri, M ;
Miccheli, A ;
Manetti, C ;
Conti, F .
BRAIN RESEARCH, 1998, 796 (1-2) :75-81
[2]  
BREMER J, 1962, J BIOL CHEM, V237, P3628
[3]  
Brooks J O 3rd, 1998, Int Psychogeriatr, V10, P193, DOI 10.1017/S1041610298005304
[4]   BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123 [J].
de Lange, ECM ;
de Bock, G ;
Schinkel, AH ;
de Boer, AG ;
Breimer, DD .
PHARMACEUTICAL RESEARCH, 1998, 15 (11) :1657-1665
[5]   Application of microdialysis in pharmacokinetic studies [J].
Elmquist, WF ;
Sawchuk, RJ .
PHARMACEUTICAL RESEARCH, 1997, 14 (03) :267-288
[6]   Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress [J].
Hagen, TM ;
Liu, JK ;
Lykkesfeldt, J ;
Wehr, CM ;
Ingersoll, RT ;
Vinarsky, V ;
Bartholomew, JC ;
Ames, BN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :1870-1875
[7]   Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency [J].
Hashimoto, N ;
Suzuki, F ;
Tamai, I ;
Nikaido, H ;
Kuwajima, M ;
Hayakawa, JI ;
Tsuji, A .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) :1729-1732
[8]   Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons [J].
Ishii, T ;
Shimpo, Y ;
Kinoshita, K ;
Kinoshita, K .
JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 83 (02) :119-124
[9]   Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier [J].
Kido, Y ;
Tamai, I ;
Ohnari, A ;
Sai, Y ;
Kagami, T ;
Nezu, J ;
Nikaido, H ;
Hashimoto, N ;
Asano, M ;
Tsuji, A .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (05) :959-969
[10]   Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency [J].
Koizumi, A ;
Nozaki, J ;
Ohura, T ;
Kayo, T ;
Wada, Y ;
Nezu, J ;
Ohashi, R ;
Tamai, I ;
Shoji, Y ;
Takada, G ;
Kibira, S ;
Matsuishi, T ;
Tsuji, A .
HUMAN MOLECULAR GENETICS, 1999, 8 (12) :2247-2254